SpletSharon Cunningham 246 views Jun 1, 2024 Sharon Cunningham, CEO and Co-founder of Shorla Pharma, shares her tips on launching a successful entrepreneurial venture as well as her vision for... SpletBioCentury's streaming commentary on biotech industry trends, plus interviews with leading KOLs. For three decades, BioCentury has given biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; industry-leading business intelligence; and global conferences.

Shorla Oncology LinkedIn

SpletShorla Pharma has raised a total of $8.3M in funding over 1 round. This was a Series A round raised on Jun 3, 2024. Shorla Pharma is funded by 2 investors. Seroba Life Sciences and Enterprise Ireland are the most recent investors. … SpletShorla Pharma Limited was set up on Friday the 29th of December 2024. Their current partial address is Tipperary, and the company status is Normal. The company has 8 directors who have also been the directors of 34 other Irish companies between them; 5 of which are now closed. Shorla Pharma Limited has 17 shareholders. mmu business and management

Shorla Pharma Announces Partnership with EVERSANA to

Splet(617) 225-4379 Shorla Pharma Profile and History Established in 2024 by Sharon Cunningham and Orlaith Ryan, Shorla Pharma is a privately held, Ireland and U.S. based specialty pharmaceutical company with an advanced pipeline of innovative oncology drugs for women's, orphan and pediatric cancers. Splet07. mar. 2024 · CAMBRIDGE, Mass., March 07, 2024--Shorla Oncology (‘Shorla’), a US-Ireland pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved the company’s ... SpletAt the Annual Meeting, the agenda includes (1) the election of four directors, (2) the approval, by non-binding advisory vote, of the compensation of our named executive officers, initiation flyboard